Renovia Inc. Finalizes the Funding Project as Led by Marc Beer
Renovia Inc. is an organization that focuses on discovering and providing digital devices used for diagnostic and therapeutic disorders of the pelvic floor in women. The company recently announced on closing a financial deal of $42.3 million, which was as a summation of the $32 million received as part of the Series B equity combined with a venture debt of $20 million. The money collected from the funding will wholly be utilized in reinforcing the Renovia’s Clinic Development in various aspects. Again, some of the areas that the funding will directly affect will include future commercial launches, the pipeline product development, and corporate development.
Moreover, the Series B funding was directed by corporates that included cormorant asset management, ascension ventures, perceptive advisors, and OSF Ventures. Other investments that also contributed to the financing were Inova Strategic Investments and BayCross Capital Group, which played the role of advising Renovia. Marc Beer, who is one of the co-founders, CEO, and chairman of the Renovia, stated that the company was pleased to be supported by some of the top healthcare ventures that were also sharing the same vision. He also added that with the support of some of this eminent healthcare investors on-board would profoundly benefit the millions of women who were already living with the pelvic floor disorders.
What’s more, Marc Beer stated that all their clients were bound to benefit from the valuable information regarding the various treatment options. With this again, would trigger Renovia’s innovative sensor technologies to combine with other healthcare investors to device even more advanced health digital platforms. Consequentially, because of this consolidation of knowledge and resources, the long term effect would result to the lowering of treatment costs of the pelvic floor disorders. Again, with the funding of this healthcare project would not only contain the current situation on the treatment of the pelvic floor conditions but also other complications associated with it such as the urinary incontinence.
About Renovia Company’s Solutions for the Urinary Incontinence in Women
It is estimated that Urinary incontinence condition affects nearly 250 women in the world. As indicated by the statistics, the disorder is quite common and troublesome condition, which is why Renovia Company strives to provide therapeutic and diagnostic solutions. The company seeks to positively impact women’s health with its FDA device that uses a mechanism that provides direct movement to the levator plate. The invention also integrates some customized apps and data for patients, hence resulting in affordable treatment for the pelvic floor conditions.
About Marc Beer
Marc Beer is a prominent businessman who has more than 25 years of experience in the development and commercializing of healthcare services. He has, for instance, had a working experience with diagnostics devices, biotechnology, and pharmaceuticals among others. Marc Beer started the Renovia Company with his co-founders Raman Iglesia and Yolanda Lorie in August 2016. Additionally, he previously worked in many companies where he was resourceful in each one of them such as ViaCell Organization and Genzyme among various others where he held senior positions. Learn more: https://www.crunchbase.com/person/marc-beer